Lu, Jiameng
Liu, Xinyi
Ji, Xiaoqing
Jiang, Yunxiu
Zuo, Anli
Guo, Zihan
Yang, Shuran
Peng, Haiying
Sun, Fei
Lu, Degan
Funding for this research was provided by:
Sponsors of this study include the Shandong province-based Collaborative Innovation Center for Intelligent Molecules with Multi-Effects and Nanomedicine (2019-01)
the National Natural Science Foundation of China (41904017)
the China Post-Doctoral Science Foundation (2021M691903)
Article History
Received: 14 August 2024
Accepted: 21 February 2025
First Online: 11 April 2025
Declarations
:
: The studies involving human participants underwent a thorough review and received approval from the Institutional Review Committee of the First Affiliated Hospital of Shandong First Medical University (Jinan, China).
: The informed consent was waived by the First Affiliated Hospital of Shandong First Medical University.
: The authors declare no competing interests.